PBYI - プ―マ・バイオテクノロジ― (Puma Biotechnology Inc)

PBYIのニュース

   Robbins Geller Rudman & Dowd LLP Announces Jury Verdict Finding Puma Biotechnology and CEO Alan Auerbach Committed Securities Fraud Results in Damages Three to Six Times Higher Than the Company Claimed  2020/09/09 00:00:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)--On September 8, 2020, a Court-appointed administrator confirmed the claims of more than 4,600 individual and institutional investors defrauded by Puma Biotechnology and its CEO, Alan Auerbach. The total damages these investors will recover, including pre- and post-judgment interest, exceed $55 million. Last year, a jury in the Central District of California found that both Puma Biotechnology and Auerbach committed securities fraud by making false and misleading state
   Puma Biotechnology to Present at the H.C. Wainwright 22nd Annual Global Investment Conference  2020/09/08 20:15:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology CEO Alan Auerbach will provide a company overview at the virtual H.C. Wainwright Global Conference on September 15, 2020.
   Puma Biotechnology to Host Conference Call to Discuss Second Quarter Financial Results  2020/07/23 20:15:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology will release its financial results and host a conference call after the close of U.S. markets on August 6, 2020.
   Acentrus Specialty Partners with Puma Biotechnology to Bring Nerlynx® (neratinib) to Health Systems and Hospitals in the Acentrus Network  2020/07/21 10:30:00 Business Wire
IRVING, Texas--(BUSINESS WIRE)--Acentrus Specialty finalizes an agreement with Puma Biotechnology, Inc. to provide qualified Acentrus clients access to NERLYNX® (neratinib).
   Puma Biotech (PBYI) Up 7.5% Since Last Earnings Report: Can It Continue?  2020/06/06 15:31:37 Zacks Investment Research
Puma Biotech (PBYI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   Puma Biotechnology to Host Conference Call to Discuss Second Quarter Financial Results  2020/07/23 20:15:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology will release its financial results and host a conference call after the close of U.S. markets on August 6, 2020.
   Acentrus Specialty Partners with Puma Biotechnology to Bring Nerlynx® (neratinib) to Health Systems and Hospitals in the Acentrus Network  2020/07/21 10:30:00 Business Wire
IRVING, Texas--(BUSINESS WIRE)--Acentrus Specialty finalizes an agreement with Puma Biotechnology, Inc. to provide qualified Acentrus clients access to NERLYNX® (neratinib).
   Puma Biotech (PBYI) Up 7.5% Since Last Earnings Report: Can It Continue?  2020/06/06 15:31:37 Zacks Investment Research
Puma Biotech (PBYI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   Moving Average Crossover Alert: Puma Biotechnology  2020/05/26 15:18:00 Zacks Investment Research
Puma Biotechnology, Inc. (PBYI) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
   Puma Biotechnology, Inc. (PBYI) Shares March Higher, Can It Continue?  2020/05/14 13:42:00 Zacks Investment Research
As of late, it has definitely been a great time to be an investor in Puma Biotechnology, Inc. (PBYI).
   Puma Biotechnology to Host Conference Call to Discuss Second Quarter Financial Results  2020/07/23 20:15:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology will release its financial results and host a conference call after the close of U.S. markets on August 6, 2020.
   Acentrus Specialty Partners with Puma Biotechnology to Bring Nerlynx® (neratinib) to Health Systems and Hospitals in the Acentrus Network  2020/07/21 10:30:00 Business Wire
IRVING, Texas--(BUSINESS WIRE)--Acentrus Specialty finalizes an agreement with Puma Biotechnology, Inc. to provide qualified Acentrus clients access to NERLYNX® (neratinib).
   Puma Biotech (PBYI) Up 7.5% Since Last Earnings Report: Can It Continue?  2020/06/06 15:31:37 Zacks Investment Research
Puma Biotech (PBYI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   Moving Average Crossover Alert: Puma Biotechnology  2020/05/26 15:18:00 Zacks Investment Research
Puma Biotechnology, Inc. (PBYI) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
   Puma Biotechnology, Inc. (PBYI) Shares March Higher, Can It Continue?  2020/05/14 13:42:00 Zacks Investment Research
As of late, it has definitely been a great time to be an investor in Puma Biotechnology, Inc. (PBYI).

calendar